Interviews, editorial viewpoints and discussions about the news and issues facing professionals involved with the design, management, conduct and reporting of clinical trials, presented by a leading membership organisation for clinical research professionals.
All content for CRfocus clinical research podcast is the property of The Institute of Clinical Research and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Interviews, editorial viewpoints and discussions about the news and issues facing professionals involved with the design, management, conduct and reporting of clinical trials, presented by a leading membership organisation for clinical research professionals.
Hugo Cervantes of Deloitte on reversing the decline of IRR in pharma R&D
CRfocus clinical research podcast
13 years ago
Hugo Cervantes of Deloitte on reversing the decline of IRR in pharma R&D
A new report from Deloitte looks at the decline in Internal Rate of Return (IRR) across pharma R&D, and suggests that improving late stage success rates has a far greater impact than reducing cost or development times. We spoke to Hugo Cervantes, one of the leading contributors to the report, about what these findings mean, and what pharma can do to improve the situation, from closer collaboration to a sharper focus on value throughout the development process.
CRfocus clinical research podcast
Interviews, editorial viewpoints and discussions about the news and issues facing professionals involved with the design, management, conduct and reporting of clinical trials, presented by a leading membership organisation for clinical research professionals.
